Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Nerve Stimulation Enhances Cognitive Function

By HospiMedica staff writers
Posted on 02 Apr 2001
A study has found that vagus nerve stimulation (VNS) can have positive effects on neurocognitive function in treatment-resistant depressed patients. More...
The study, led by Harold A. Sackeim, Ph.D., of the New York State Psychiatric Institute, was published in the January 2001 issue of Neuropsychiatry, Neuropsychology, and Behavioral Neurology.

In a study of VNS as a depression treatment, researchers performed a battery of neuropsychological tests on 27 patients with treatment-resistant depression before and after ten weeks of VNS therapy. The 13 tests evaluated skills such as motor speed, psychomotor function, language, attention, memory, and executive function. The results showed no evidence of deterioration in any of these skills after treatment with VNS, and there were marked improvements in many cases.

VNS therapy is delivered by an implantable medical device similar to a cardiac pacemaker. A stopwatch generator is surgically implanted in the left chest and a nerve stimulation electrode is attached to the vagus nerve in the neck in a one-to-two hour procedure. Using an external programmer, the doctor can set or reset the stimulation parameters of the device. The system delivers preprogrammed intermittent electric pulses to the vagus nerve 24 hours a day. In another study, VNS was found to have a positive influence on the quality of life of epilepsy patients, although study results showed no clear cognitive changes. VNS was developed by Cyberonics, Inc. (Houston, TX, USA).

"Our data suggest that VNS can produce a mildly improved sense of physical, emotional, and social well-being, and these improvements are not necessarily tied to relief from seizures,” said Carl B. Dodrill, Ph.D., neuropsychologist, University of Washington Regional Epilepsy Center.



Related Links:
Cyberonics

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.